Sparsentan (PS-433540,RE-021,DARA)
CAS: 254740-64-2
Ref. 3D-EKA74064
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
Sparsentan is an investigational drug that acts as a selective, orally available, small-molecule inhibitor of the enzyme TGR5. It has been shown to have efficacy in animal models for metabolic disorders and infectious diseases such as atherosclerotic cardiovascular disease, cerebrotendinous xanthomatosis, monoclonal antibody-associated glomerulonephritis, diabetic neuropathy, and ldl-c lowering. Sparsentan is currently undergoing phase 2 clinical trials for type II diabetes mellitus.
Chemical properties
Technical inquiry about: 3D-EKA74064 Sparsentan (PS-433540,RE-021,DARA)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
